RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Acumen Pharmaceuticals Stock

Acumen Pharmaceuticals Net Income 2024

Acumen Pharmaceuticals Net Income

-80.99 M USD

Ticker

ABOS

ISIN

US00509G2093

In 2024, Acumen Pharmaceuticals's profit amounted to -80.99 M USD, a 54.65% increase from the -52.37 M USD profit recorded in the previous year.

The Acumen Pharmaceuticals Net Income history

YEARNET INCOME (undefined USD)
2029e-
2028e-
2027e-
2026e-
2025e-
2024e-
2023-
2022-
2021-
2020-
2019-

Acumen Pharmaceuticals Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Acumen Pharmaceuticals, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Acumen Pharmaceuticals from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Acumen Pharmaceuticals’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Acumen Pharmaceuticals. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Acumen Pharmaceuticals’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Acumen Pharmaceuticals’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Acumen Pharmaceuticals’s growth potential.

Acumen Pharmaceuticals Revenue, EBIT and net profit per share

DateAcumen Pharmaceuticals RevenueAcumen Pharmaceuticals EBITAcumen Pharmaceuticals Net Income
2029e52.11 M undefined0 undefined-56.99 M undefined
2028e13.53 M undefined-138.63 M undefined-69.25 M undefined
2027e0 undefined-127.5 M undefined-87.02 M undefined
2026e0 undefined-112.84 M undefined-99.89 M undefined
2025e0 undefined-99.48 M undefined-94.07 M undefined
2024e0 undefined-79.16 M undefined-80.99 M undefined
20230 undefined-61.14 M undefined-52.37 M undefined
20220 undefined-45.24 M undefined-42.86 M undefined
20210 undefined-19.58 M undefined-100.61 M undefined
20201.44 M undefined-7.91 M undefined-7.33 M undefined
20191.7 M undefined-7.81 M undefined-7.69 M undefined

Acumen Pharmaceuticals stock margins

The Acumen Pharmaceuticals margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Acumen Pharmaceuticals. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Acumen Pharmaceuticals.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Acumen Pharmaceuticals's sales revenue. A higher gross margin percentage indicates that the Acumen Pharmaceuticals retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Acumen Pharmaceuticals's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Acumen Pharmaceuticals's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Acumen Pharmaceuticals's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Acumen Pharmaceuticals. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Acumen Pharmaceuticals's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Acumen Pharmaceuticals Margin History

Acumen Pharmaceuticals Gross marginAcumen Pharmaceuticals Profit marginAcumen Pharmaceuticals EBIT marginAcumen Pharmaceuticals Profit margin
2029e0 %0 %-109.37 %
2028e0 %-1,024.65 %-511.81 %
2027e0 %0 %0 %
2026e0 %0 %0 %
2025e0 %0 %0 %
2024e0 %0 %0 %
20230 %0 %0 %
20220 %0 %0 %
20210 %0 %0 %
20200 %-549.31 %-509.03 %
20190 %-459.41 %-452.35 %

Acumen Pharmaceuticals Aktienanalyse

What does Acumen Pharmaceuticals do?

Acumen Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Acumen Pharmaceuticals's Profit Margins

The profit margins of Acumen Pharmaceuticals represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Acumen Pharmaceuticals's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Acumen Pharmaceuticals's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Acumen Pharmaceuticals's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Acumen Pharmaceuticals’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Acumen Pharmaceuticals stock

How much profit has Acumen Pharmaceuticals made this year?

Acumen Pharmaceuticals has made -80.99 M USD this year.

How has the profit developed compared to last year?

The profit has increased by 54.65% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Acumen Pharmaceuticals publish its earnings?

Acumen Pharmaceuticals publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Acumen Pharmaceuticals?

The profits of Acumen Pharmaceuticals are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Acumen Pharmaceuticals?

You can learn more about the earnings of Acumen Pharmaceuticals by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Acumen Pharmaceuticals pay?

Over the past 12 months, Acumen Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Acumen Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Acumen Pharmaceuticals?

The current dividend yield of Acumen Pharmaceuticals is .

When does Acumen Pharmaceuticals pay dividends?

Acumen Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Acumen Pharmaceuticals?

Acumen Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Acumen Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Acumen Pharmaceuticals located?

Acumen Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Acumen Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Acumen Pharmaceuticals from 9/13/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/13/2024.

When did Acumen Pharmaceuticals pay the last dividend?

The last dividend was paid out on 9/13/2024.

What was the dividend of Acumen Pharmaceuticals in the year 2023?

In the year 2023, Acumen Pharmaceuticals distributed 0 USD as dividends.

In which currency does Acumen Pharmaceuticals pay out the dividend?

The dividends of Acumen Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Acumen Pharmaceuticals

Our stock analysis for Acumen Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Acumen Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.